We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD

News   Feb 01, 2012

 
REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD
 
 
Advertisement
 

RELATED ARTICLES

A Mirror-image Peptide Tumor Treatment

News

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

READ MORE

RNA Key in Helping Stem Cells Know What To Become

News

New research concludes that RNA plays an indispensable role in cell differentiation, serving as a bridge between our genes and the epigenetic machinery that turns them on and off.

READ MORE

Light-activated Nanoparticles Inhibit Tumor Growth

News

A unique nanoparticle to deliver a localized cancer treatment inhibits tumor growth in mice, according to new research conducted at Penn State University.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE